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Community Introduction of Practice Parameters for Autistic
Spectrum Disorders: Advancing Early Recognition
Laurent Holzer,1,3 Raluca Mihailescu,2 Catherine Rodrigues-Degaeﬀ,1 Laurent Junier,1 Carole
Muller-Nix,1 Oliver Halfon,1 and Franc¸ois Ansermet1
Objectives: Within a strong interdisciplinary framework, improvement in the quality of care
for children with autistic spectrum disorders through a 2 year implementation program of
Practice Parameters, aimed principally at improving early detection and intervention.Method:
We developed Practice Parameters (PPs) for Pervasive Developmental Disorders and
circulated the PPs to all child and adolescent psychiatrists practicing in the region. Results:
PP development and parallel information strategies resulted in a signiﬁcant decrease of
1.5 years in the mean-age-at-diagnosis. However, further analysis indicated that improvement
was only transient. Conclusion: Despite the encouraging improvement in mean-age-at-
diagnosis 2 years after PP implementation, other indicators showed a failure to maintain the
improvements. A systematic screening program would be the most reliable method to
reinforce the PPs.
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INTRODUCTION
Autistic spectrum disorders, among the most
challenging of child psychiatric problems, severely
affect development and carry major risk of chronic
impairment and disability. Such poor prognosis
requires clinicians to be active in the early phase of
child development, aiming for prompt detection and
rapid application of research ﬁndings to clinical
practice. While recent reports suggest an advance
in understanding the physiopathology of ASDs,
treatment issues remain controversial and the inci-
dence rate continues to rise (Fombonne, Simmons,
Ford, Meltzer, & Goodman, 2001; Gillberg & Wing,
1999).
Despite the expanded efforts in western coun-
tries to advance early intervention, the mean-age-at-
diagnosis remains too high. Even in areas that use
systematic screening and follow-up, there is a real gap
between the kind of careful screening done in
research programs and the clinical reality of age at
referral. Fombonne et al. mention that whereas
parental concerns occur between 15 and 22 months
of age, the ﬁrst contact with a specialist takes place
nearly a half-year later, between 20 and 27 months.
Then it is not until a mean age of six years that these
children receive a highly specialized assessment (De
Giacomo & Fombonne, 1998). A recent report also
raised the issue of disparities between mean-ages-at-
diagnosis for two racial groups: white children were
diagnosed as autistic at a mean 6.3 years of age,
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compared with 7.9 years for African-American
children (Mandell, Listerud, Levy, & Pinto-Martin,
2002).
Growing research data, multiple etiology
hypotheses, and a variety of clinical expressions of
these disorders often leave the clinician overwhelmed
by information, yet paradoxically lacking in relevant
practice knowledge. While many studies on screening
and early intervention lead one to believe that
diagnosis at a younger age is achievable, what
concrete methods can a clinician use to gain earlier
access to these children and improve their prognoses?
While translating scientiﬁc evidence into clinical
practice remains a complex and challenging goal for
authors of clinical guidelines (Davis & Taylor-Vaisey,
1997), useful Practice Parameters (PPs) should ﬁt a
clinician’s expectations as well as improve the quality
of care of autistic children.
CONTEXT
The Regional PDD Situation
Autism and related pervasive developmental
disorders have an estimated minimum prevalence of
18.7 per 10,000 (Fombonne, 1999). This should lead
to an incidence of approximately 20 new cases a year
for the Swiss canton of Vaud, which has approxi-
mately 8000 births per year. Approximately 30–40
new cases of ASD present to the Lausanne University
Child and Adolescent Psychiatry Service (UCAPS)
facilities each year. See Appendix B.
There is no systematic screening for ASDs in the
canton. Between 9 months and 4 years of age,
children are not required to see a physician (for
vaccinations, for example). The Lausanne UCAPS
includes 41 of the 103 child psychiatrists practicing in
the canton and offers a specialized joint consultation
for ASDs. It also maintains some 100 places for
providing institutional care in a day hospital. Child
psychiatrists do not necessarily see all the children
who present with symptoms of ASD. Considering the
nature of the problems that require assessment and
specialized care, most cases of ASDs are referred to
the public health care sector covered by UCAPS,
while the private sector is overloaded and has long
waiting lists of patients seeking appointments. Case
numbers and mean-age-at-diagnosis over a 4 year
period (1996–1999) were as follows: (see Table I).
In an area where nursery school can begin at the
age of 4 and obligatory primary school starts at the
age of 6, the mean-age-at-diagnosis is slightly over
6 years. This is the age at which the child is ﬁrst seen
in the service, with the diagnosis following within
approximately 1 month. Nearly all of these children
are referred to the UCAPS by their pediatrician or
their school (based on suspicion of ASD), prior to
actual diagnosis.
Thus, the principal problem identiﬁed was a
mean-age-at-diagnosis that was particularly high in
comparison with other studies (Baron-Cohen, Allen,
& Gillberg, 1992; Gray & Tonge, 2001). Most authors
believe that early detection and treatment are impor-
tant to ensure the best treatment results. It is generally
accepted that early acquisition of communicative and
Table I. New Cases of PDD Over a 4 Year Period (1996–1999)
Diagnosis* n Mean age (in years)
Childhood autism 15 4.9
Atypical autism 17 5.2
Rett’s syndrome 0 –
Other childhood disintegrative disorder 10 7.0
Hyperactive disorder associated with mental retardation and stereotyped movements 0
Asperger’s syndrome 7 7.7
Other pervasive developmental disorders 46 6.1
Pervasive developmental disorder not otherwise speciﬁed 81 6.3
Total n = 176 Grand M = 6.1 years
*Patients are diagnosed by senior psychiatrists according to the ‘‘ICD 10 criteria’’ (clinical descriptions and diagnostic guidelines). Use of
valid diagnostic tools is not systematic.
The unusual diagnostic distribution with an overrepresentation of PDD-NOS and ‘‘other PDD’’ is certainly a consequence of transcoding.
CFTMEA [the French classiﬁcation of mental disorders of children and adolescents—(Mise`s et al., 1988)] recommends the PDD-NOS
transcoding for what they call ‘‘psychotic disharmony,’’ a quite frequent and popular diagnosis in French-speaking, psychoanalytically
oriented child psychiatry. Experienced clinicians familiar with the CFTMEA tend to refer to the transcoding recommendation instead of the
ICD 10 criteria themselves.
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representational skills inﬂuences later verbal and
social capacities. This emphasizes the importance of
early intervention to improve the development of
these fundamental precursors (Robins, Fein, Barton,
& Green, 2001; Rutter, 1999; Sigman, 1999). From
this point of view, mean-age-at-diagnosis is an impor-
tant indicator, and lowering this age becomes a
prerequisite for improvement in the quality of care.
Disparities in Clinical Practice
Clinical practice cases show that the care process
can be disrupted at several stages. At the detection
phase, there is a tendency to minimize or to diagnose
ASDs only as a last resort. We observed wide
variations in clinical practice at the diagnostic assess-
ment phase (which is often long and sometimes
insufﬁciently coordinated) and the treatment plan-
ning level (using criteria that do not necessarily take
into account either medical indications or scientiﬁc
evidence). Certain children beneﬁted from a thorough
neuro-pediatric and/or child psychiatric assessment.
Others were integrated into care structures or schools
without any specialized medical assessment.
A Joint Consultation of Neuro-Pediatrics and Child
Psychiatry (JCNC)
As autism and PDD are neuro-psychiatric devel-
opmental disorders, both child neurologists and child
psychiatrists are involved in this ﬁeld. In clinical day-
to-day practice, parents and children deal with one
medical specialist rather than with two or more
professionals. We attempted to remedy this common
division of care management through a joint consul-
tation for children suffering from developmental
disorders. This integrates the biological, neuro-psy-
chological, and child psychiatric points of view into a
multidisciplinary perspective, and provides a treat-
ment plan that takes into account these different
aspects. A child neurologist, a child psychiatrist, and
a psychologist conduct this joint consultation.
The Regional Health Service’s ‘‘Quality Program’’
Promoting the quality of care is part of the
mission of our regional health service, which
launched a Quality Program across the various care
providers (Graz, Vader, Burnand, & Paccaud, 1996).
Quality management in health care aims to improve
health outcomes, but is still under development in the
current Swiss context. Economic issues and restric-
tions are also part of quality management in health
care projects, although not to the extent that we
observe in the USA context (Jellinek, 1999).
OBJECTIVES
We decided to develop and implement PPs for
early diagnosis and treatment of children with ASDs.
Our aim was to improve the clinical system in the
region by reducing mean-age-at-diagnosis so as to
improve long term outcomes, increase referrals to
child psychiatrists, and improve the clinical identiﬁ-
cation process. The goal of our PPs was to provide
clear recommendations, give an overall view of the
questions, and standardize practices of detection,
diagnosis, and treatment planning for children up to
4 years old who present developmental problems. We
placed special emphasis on developing concrete
measures, as PPs are operationally grounded in the
clinical ﬁeld. Given the potentially negative label of
autism/Pervasive Developmental Disorders (ASDs),
we focused on early detection of children at risk for
ASDs rather than children with ASDs.
Generally, our pilot program objectives were not
strictly part of a clinical research project aimed at
evaluating an original hypothesis on autism and
PDD. Rather, we sought to test the following
hypothesis: the development and implementation of
PPs allows for improved quality of care in the ASD
clinical ﬁeld by improving certain indicators, notably
the mean-age-at-diagnosis.
METHOD
Our quality care assurance project was a two-
year (April 1998–April 2000) action research pro-
gram to develop and implement PPs supported by the
promotion of active interdisciplinary coordination
for early detection and diagnosis of ASDs. In order
to encourage and develop a culture of ‘‘quality
orientation’’ within the academic hospital services,
the project directors worked to improve the quality of
care by providing ﬁnancial support. Complicated
care pathways and complex clinical problems posed
by children presenting ASDs focussed the project on
developing PPs. Weekly meetings with JCNC clini-
cians anchored this project in the concrete reality the
group’s goal to become a cantonal reference for ASD
issues. The complexity of care networks and the
personal and institutional stakes of the professionals
involved in ASDs engendered a variety of reactions
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that required many adjustments in setting up the
project. In spite of these obstacles, a pragmatic
approach gradually developed to tighten the objec-
tives of improving early identiﬁcation and follow-up.
The evaluation of the impact of PPs circulation
was conducted by analyzing the medical ﬁles of the
JCNC and the other divisions of the service, as well as
by analyzing statistical data gathered for all the
children followed in the service. The second author
(RM, independent from the UCAPS) consulted the
ﬁles of all 69 children for whom the service had made
a ASD diagnosis in 1999 and 2000. She examined the
trajectory of care, the clinical assessment performed,
and the treatment plan proposal when available. We
systematically summarized other data, such as inves-
tigation requests and telephone advice based on
clinical descriptions.
Mean age at diagnosis was our main indicator.
Data came from computerized medico-administrative
ﬁles, which staff members complete within the month
following admission of the child. We hypothesized
that the intervention program would also increase the
referral of children with a suspicion of ASD to the
JCNC or to a child psychiatry consultation, and that
children with ASDs would be more likely to receive a
complete assessment.
Other indicators we used were operationalized as
follows:
1. The number of children beneﬁting from a
complete assessment. We considered a case to
be complete when the child had beneﬁted
from a child psychiatrist consultation, a
pediatric consultation, a formal audiologic
assessment, a psychometric evaluation, and at
least one standardized and validated diag-
nostic tool.
2. Use of the PPs by the clinicians: We consid-
ered the PPs to have been followed when the
case was complete and all ﬁve stages men-
tioned in point #II) had been achieved and at
least one of the recommended tools in points
#2 and #3 had been used.
3. Number of children referred by practicing
pediatricians: information contained in the
medical ﬁle.
4. Number of children referred to the JCNC:
activity of the JCNC that appears in the
medical statistics of the UCAPS.
5. Number of children referred to the JCNC
based on a suspicion of PDD.
6. Number of PDD diagnoses conﬁrmed.
Development of PPs
We developed our PPs by scrupulously following
the twenty-two PP guidelines developed by Burnand
(1999) for the Center of Clinical Epidemiology. We
compiled information from two research databases
(MEDLINE and PSYCLIT), from Internet sites
dedicated to ASDs, and from numerous ASD arti-
cles, books, and other works. PPs must consider the
local context in which they are developed (theoretical
orientation, practitioners’ training, local resources in
speciﬁc specialties, educational institutions, existing
therapeutic practices, etc.). We submitted the PPs for
evaluation to three external experts: Prof. Isabelle
Rapin, Prof. Bernard Golse, and Prof. Pierre Ferrari.
Concrete clinical results in a community-based setting
were the underlying incentive for our approach,
rather than the simple development of PPs. In seeking
to lower the mean-age-at-diagnosis, we adopted an
information strategy aimed at professionals involved
with children at risk for ASDs.
Publication and Circulation of the PPs
The PPs were issued throughout the region along
with an explanation of the goals of our approach.
The PPs addressed early detection and diagnosis,
diagnostic investigations, and treatment plans. See
Appendix A.
Early Detection and Diagnosis
ASDs had not been a target for systematic
regional screening. Moreover, the Swiss health care
system does not facilitate early screening strategies, as
pediatrician visits are not systematically conducted
between the ages of 9 months and 4 years. On the
other hand, early signs of autism and other PDDs are
neither pathognomonic nor even speciﬁc [i.e., sleep
disturbances, gaze monitoring abnormalities, low
interest in communication (Tanguay, Robertson, &
Derrick, 1998)]. As non-speciﬁc signs can be found in
many normal situations, they do not automatically
warrant a specialized consultation; cost, availability
of specialists, or even the anxiety generated in the
parents and/or child are all dissuasive factors. How-
ever, given the potentially serious nature of these
disorders, early intervention is warranted. Although
the validity of early diagnosis and the eﬃcacy of early
treatment have not been formally demonstrated
scientiﬁcally, there are converging arguments sup-
porting the importance of early detection and treat-
ment (American Academy of Child and Adolescent
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Psychiatry Oﬃcial Action, 1999; Filipek et al., 1999,
2000; McEachin, Smith, & Lovaas, 1993; Rutter,
1999; Sauvage & Hameury, 1990; Sigman, 1999).
Our detection strategy involved the following
sequential steps leading either to the JCNC or to
another child psychiatry consultation.
1. Sensitization of the ﬁeld, that is, familiarizing
various early childhood professionals (nursery school
personnel, day care workers, specialized social work-
ers, educators) with developmental issues and with
non-speciﬁc signs of possible ASDs problems, such as
social withdrawal, abnormalities in social reciprocity,
sharing enjoyment, directing attention, etc. To avoid
a drift towards alarmist positions and abusive diag-
nosis, we emphasized that the identiﬁcation by ﬁeld
professionals of non-speciﬁc signs should be merely a
starting point for a consultation by a pediatrician or
family doctor.
2. Informing pediatricians and general practitio-
ners of a speciﬁc tool: the CHAT [Checklist for
Autism in Toddlers, by Baron-Cohen et al. (1996)].
Our choice of this tool was motivated by its simplicity
of use, precise item deﬁnitions, high speciﬁcity, and
overall validity. Its sensitivity, however, was lower
than expected, according to recent follow-up data to
the age of seven (Baird et al., 2000). While it is not a
diagnostic tool, it does identify children at risk. A risk
proﬁle of a child who presents non-speciﬁc signs
should lead the pediatrician or primary care physi-
cian to refer the child to a child psychiatric consul-
tation or to the JCNC.
3. Investigative steps (by the JCNC or a child
psychiatrist) to conﬁrm or invalidate the diagnostic
hypothesis of a child at ASD risk, and to prepare a
treatment plan for conﬁrmed cases.
Diagnostic Investigations
A number of steps were formalized in accor-
dance with the recommendations developed by the
AACAP (American Academy of Child and Adoles-
cent Psychiatry Ofﬁcial Action, 1999) and are
described in Appendix A.
We emphasized the importance of a detailed
assessment that evaluated a variety of factors, such as
medical history, pediatric examination, child psychi-
atric observation, neurological assessment, psycho-
logical assessment, laboratory investigations, and
the child’s immediate domestic and socioeconomic
environment. We recommended the use of standard-
ized assessment tools, such as the Childhood Autism
Rating Scale (Schopler, Reichler, DeVellis, & Daly,
1980), the Pre-Linguistic Autism Diagnostic Obser-
vation Schedule (Dilavore, Lord, & Rutter, 1995) and
the Psycho-Educational Proﬁle-Revised (Steerne-
mann, Muris, Merckelbach, & Willems, 1997).
Despite limitations of the CARS regarding its unitary
conception (Stella, Mundy, & Tuchman, 1999) and a
tendency to overdiagnose autism with the current cut-
oﬀ score at 30 (Lord, 1997), this tool provide useful
and reliable information at a broad community level.
We also focused on symptom variation, notably as a
function of age.
The psychiatrists’ clinical impressions are a part
of the assessment, and the ﬁnal diagnosis will be
based as much on the clinician’s opinion as on the
results of the assessment scales. Differentiating chil-
dren at risk for autistic spectrum disorders from
children with autistic spectrum disorders is a complex
issue. From our point of view, no clear border can be
established by any standardized tool. A clinical
diagnosis of autism, conﬁrmed with a diagnostic tool
(CARS>37 for example), will lead to an autism
diagnosis. A clinical impression of autism, not con-
ﬁrmed with any diagnostic tool (or a signiﬁcant score
on a diagnostic tool without clinical impression), is
likely to moderate diagnosis certainty. In such cases,
a diagnosis of atypical autism (CARS between 30 and
37) or PDD-NOS (CARS<30) is given, and the ‘‘at
risk’’ condition is reserved for very young children
who do not meet all diagnostic criteria for an autistic
spectrum disorder. We are dealing here with uncer-
tainty coming from clinical age-related features with
prognosis implications that are taken into account by
the ‘‘at risk’’ notion. The establishment of the ﬁnal
diagnosis is a synthesis resulting from meetings of
senior child psychiatrists, physicians who examined
the child, and the psychologist who had tested the
child.
Treatment Plans
At the end of the diagnostic assessment, a
treatment plan was developed. The plan chosen
depended largely on the wishes of the parents, and
its orientation depended on the availability of alter-
natives in each therapeutic area.
No single treatment has been shown clearly
superior to others in terms of therapeutic results
(Gresham & MacMillan, 1997). Nor are there formal
elements that would permit us to exclude any
particular form of treatment, arguing that it is
ineﬀective or even harmful. Nor is there a clear
consensus in favor of a speciﬁc method, but there is
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evidence to support a multidisciplinary therapeutic
approach (Danion-Grilliat, 1996; Gilman & Tuch-
man, 1995; Ozonoﬀ & Cathcart, 1998; Reid, Balis, &
Sutton, 1997; Rutter, 1999) and the eﬀectiveness of
educational interventions (Koegel, Koegel, &
McNerney, 2001; Ozonoﬀ & Cathcart, 1998). Further
research is needed to evaluate the various therapeutic
possibilities and their respective indications.
Actions Undertaken
We conducted a variety of activities aimed at
advancing the early detection and diagnosis of ASDs.
We made announcements and initiated discussions in
various child care facilities, published articles in a
targeted journal (Holzer, 2000; Rodrigues-Dagaeﬀ
et al., 1999), and circulated the Checklist for Autism
in Toddlers (CHAT) (Baron-Cohen et al., 1996) to all
97 pediatricians of the Canton of Vaud and to 59
targeted general practitioners. We issued the PPs to
all 103 child psychiatrists in the canton. The PPs were
not issued to pediatricians and general practitioners
because the volume of information was too great and
the PPs dealt with a relatively specialized question for
which most practitioners have ‘‘limited time.’’ On the
other hand, neuro-pediatricians and pediatricians in
the development unit, who were direct partners in the
Common Consultation (CCNP) project, did receive
the PPs. An important project objective was to
simplify the care pathways and to encourage special-
ized assessments by the CCNP or by a consulting
child psychiatrist whenever possible.
At the end of the project, information about the
PPs had been relayed and actively sustained through
March 2000. PPs were systematically distributed every
6 months to all new physicians and psychologists in
the UCAPS. The ﬁnal report of the project with the
PPs was available on the website of the Hospices
Cantonaux (http://www.hospvd.ch/qualite/). How-
ever, the referral network had not been directly
sustained as it had been during the project.
RESULTS
Lowering Mean-Age-at-Diagnosis
This is an indispensable ﬁrst step for improving
the level of care and establishing conditions for
optimal treatment. It is the clearest indicator of the
effectiveness of early detection and diagnosis efforts.
We were thus encouraged that, following the intro-
duction of the PPs, the mean-age-at-diagnosis
dropped 1.5 years from age 6 to 4.5 [p<.01] in 2000
(See Table II).
During the same period, the University of
Geneva’s child and adolescent psychiatry service
(serving a population of about 414,000 with 4600
annual births) diagnosed 56 cases of autism or other
PDDs. These had a mean age of 5.1 years that
increased slightly between 1999 and 2000. Although
these ﬁgures are not truly comparable, these data
support the claim that the intervention program was
responsible for the drop in mean-age at diagnosis in
Vaud.
However, improvement was only transient; it
disappeared as soon as the Quality Assurance in
Health Care program ended.
Other Indicators
Variations in these indicators are shown in
Table III. Slight improvements were indicated in the
following areas: (a) increase in the number of children
referred to consultation by external pediatricians, (b)
increased consultation activity, notably for children
suspected to have ASDs, (c) increase in the number of
children beneﬁting from a complete assessment, and
(d) application of the PPs by many practitioners.
Like mean-age-at-diagnosis, most of these indi-
cators showed a return to previous levels after the
program ended. The observed increase in referral to
the JCNC stabilized while requests for expert opinion
and telephone counseling increased.
DISCUSSION
Interest in the Project
Increasing interest in evidence-based medicine
has lead to many developments of practice parame-
ters (PPs). Despite their evolving scientiﬁc rigor and
applicability, PP implementation in practice remains
uncertain and their effects on quality of care are
unclear and difﬁcult to assess (Hayward, 1997).
However, our Quality Assurance in Health Care
program was instructive regarding its inﬂuence on
day-to-day practice. This sort of intervention
research attempts to translate research ﬁndings into
practice and aims to improve the quality of health
care in rough but signiﬁcant indicators. Our type of
program is likely to modify temporarily some clinical
practices and shows some improvement in key quality
of care indicators. It is also cost eﬀective in that it
uses existing resources (clinicians, service logistics,
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and information technology) coordinated by a psy-
chologist whose position was the essential element
ﬁnanced by the project.
The PPs were an obvious support for clinicians,
promoting early detection of ASDs and sensitizing
the project partners to what was at stake. The
implementation of PPs is an interesting and stimu-
lating exercise, potentially capable of modifying daily
attitudes and behaviors in the clinic, but in practice, it
comes up against several obstacles.
As this project has primarily served the JCNC, it
can be seen as an attempt to promote a child
psychiatric approach in the ﬁeld of ASDs. The
regional context of Vaud, with a high density of
child psychiatrists, makes the JCNC an operational
solution. Delays for referral are much longer in child
neurology and developmental pediatrics (a minimum
of 6–9 months). Therefore, our aim to increase
referral to child psychiatrists is certainly not to the
detriment of child neurologist, developmental pedia-
trician, or psychologist. Child psychiatrists, given
their high number in the canton, are an optimal
resource for ASDs (looking beyond the common
quarrels between medical specialties). As in other
kinds of medical activity, the concept of ‘‘critical
mass’’ must also be taken into account. Experience
and expertise can only be acquired by seeing a
sufﬁcient number of children who present these kinds
of problems. We place expertise on the side of
medical art and not solely on the side of fundamental
science, while recognizing that the two approaches
are not exclusive. Indeed, each complements and
enriches the other. The expertise behind this
approach is one of an experienced clinic that inte-
grates the most recent data in the ASD literature
without assuming absolute certainty in ruling out all
rare causes that could have a link to ASDs. The
JCNC seemed ideally situated for progressively
acquiring expertise and legitimated the effective
support brought by the project.
Limitations of the Methodology
Several methodological limitations could reduce
the general implications of our project. While the
program was designed to serve the entire canton, it
aimed above all to improve the identiﬁcation and
diagnosis of developmental problems in children. The
methodology did not count all the children in the
canton, nor did it measure the effect of the PP
program on the children presenting ASD problems.
Epidemiological data indicates that the number of
children arriving at the UCAPS service is higher than
the expected annual number of new cases. This
suggests that UCAPS consultants eventually see most
children with developmental disorders. While we
strongly encouraged the use of better case identiﬁca-
tion strategies, we did not directly check to make sure
they were followed, nor did we verify with pediatri-
cians the manner in which they used the CHAT. It
was through reviewing the patient ﬁles of UCAPS
child psychiatrists that we veriﬁed the degree to which
they followed recommendations (PPs).
We carried out the entire undertaking in a spirit
of persuasion so as to promote increased surveillance
and encourage early identiﬁcation of suspected devel-
opmental disorders. A systematic assessment pro-
gram would have required far greater resources, as
well as an obligatory evaluative framework, in order
to be effective. Moreover, a systematic screening and
identiﬁcation program would have been particularly
difﬁcult to set up, given the established patterns of

















1999 37 14 83 47 19 18 9 4
2000 32 18 101 53 22 10 19* 13*
*p<.05.
Table II. Mean-Age-at-Diagnosis of New Cases of PDD
1997 1998 1999 2000 2001
N of new PDD cases 33 42 37 32 30
Mean Age 5.9 (±2.2) 6.1 (±1.2) 6.1 (±2.1) 4.6* (±1.5) 6.6 (±1.3)
*p<.01.
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health care practice and the organization of primary
schooling in the canton.
Diagnostic reliability does not depend on a
speciﬁc methodology systematically using a standard-
ized diagnostic procedure or a validated diagnostic
tool. Rather, it emerges from the work of senior
psychiatrists who may or may not use speciﬁc
diagnostic tools. This practice characteristic does
not respond well to a requirement for standardized
diagnostic procedures; it simply reﬂects the daily fact
of clinical work in the ‘‘real world’’ of the Canton of
Vaud.
The suspected tendency to diagnose autism or
PDDs only when fairly certain, and conﬁrmed by the
child’s development over several months or years,
could explain much of the delayed diagnosis that we
observe in our service. However, because of the
requirement to diagnose within a month of admis-
sion, and knowing that there are no ‘‘waiting to see’’
diagnostic categories in the ICD 10, this hypothesis is
not terribly plausible. The most commonly used PDD
categories—PDD-NOS and ‘‘other PDD’’—are gen-
eral categories that can be prudently used to describe
provisional suspicions of autism, contingent on a
more reﬁned diagnosis. While neither rigorous nor
scientiﬁc, this attitude reﬂects how weaknesses in
nosology may be used for clinical convenience.
Diagnostic Accuracy
The question of the reliability of early diagnosis
has been raised by many authors (Filipek et al., 1999;
Gray & Tonge, 2001; Stone et al., 1999). The age at
which it is possible to diagnose reliably autism or
PDDs remains a controversial question. Several
studies on this issue have postulated relative diag-
nostic stability at the age of 18 months (Baird et al.,
2000). Importantly, not all DSM or ICD criteria can
be fulﬁlled, because approximately 3 years of age are
required for a complete picture of typical autism
(Robins et al., 2001). While looking for reliable early
diagnostic criteria that oﬀer high predictive validity
with good sensitivity and speciﬁcity, the notion of
autistic risk or risk of ASDs seems to us an interesting
compromise. It does not prematurely shut the child
into a state of ASD, but allows for a more open
prognosis while underscoring the importance of early
intervention aimed at reducing the risk of evolution
toward ASDs. However, this compromise is not
systematic; it remains optional according to the
clinician’s own perception.
Promising new tools for early identiﬁcation
suggest that systematic screening and follow-up will
develop and become much more reliable. Whereas
initially the large-scale use of the CHAT spurred
great interest and high hopes, the long-term follow-
up revealed weaker sensitivity than foreseen for this
diagnostic tool. In an attempt to remedy this prob-
lem, a ‘‘Modiﬁed CHAT’’ version was recently
developed (Robins et al., 2001). The initial results
appear to be encouraging; they conﬁrm that system-
atic diagnosis is both feasible and increasingly reli-
able. The legitimate fears about false positives
(incorrect early diagnosis of ASD) should be miti-
gated by the fact that the children tested present a
range of developmental problems for which some
kind of care is justiﬁed. The risk of diagnosing as
pathological a developmental pattern that is simply a
variant of the normal appears weak to us. In almost
all cases, it is more the speciﬁc diagnosis of autism or
some other developmental disorder that challenges
clinicians, rather than a broader diagnosis of devel-
opmental diﬃculty. It is, of course, important that
the reliability of speciﬁc diagnoses in autism spectrum
disorders improves to oﬀer equally speciﬁc care and
treatment options. It would be unrealistic to advance
systematic screening and diagnosis without the sup-
port of PPs, because diagnosis is only one of the
(certainly fundamental) links in the total process of
oﬀering optimal care downstream from the diagnosis.
Barriers to the Use of PPs
Our results support the ﬁndings of Davis and
Tailor-Vaisey, who have shown that the use of
methods that are practice- and community-based
rather than didactic are more effective in the adop-
tion of clinical practice recommendations (Davis &
Taylor-Vaisey, 1997).
Barriers to the successful implementation of PPs
and the achievement of beneﬁcial secondary effects
on health outcomes have been well-described (Hay-
ward, 1997). Many diﬃculties have been reported
concerning the application of PPs (Cabana et al.,
1999). The following have been conﬁrmed by clini-
cian interviews: (a) unfamiliarity with the procedure,
(b) the high volume of information, (c) the time
required in order to understand and implement the
program, (e) disagreements over ‘‘cookbook’’ guide-
lines, (f) the extra work involved, (g) low expectations
concerning results, (h) a lack of motivation, and (i)
the inertia of routine and habit.
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More speciﬁcally, the low level of proof in the
ASD ﬁeld seems limiting. An examination of the
question leads to PPs being locally adapted, but a
broader reach does not have strong grounding in
evidence. Our PPs were intentionally indicative rather
than directive. In order to advance ﬂexibility in the
use of PPs, we avoided guidelines that were too
precise. As a result, the PPs themselves may be
effective through a general sensitization rather than a
speciﬁc application. Although we do not have empir-
ical data to support this claim, a general approach
may be less effective than a more speciﬁc and
directive approach with a decision algorithm, such
as the American Academy of Neurology has devel-
oped under the leadership of Filipek et al. (2000). A
substantial limitation is the practical diﬃculty of
treatment planning in the face of quotas in the
receiving structures for children presenting ASDs.
This can bring about disillusionment and lower
expectations of concrete results. Many could easily
question the eﬃcacy of early detection and exhaustive
assessment if there is no course of treatment for
several years. However, the establishment of this
common consultation was accompanied by a moni-
toring and medium-term ambulatory care structure
for 0–3 years. We considered that care downstream
from the JCNC was assured, as this downstream care
structure had never been saturated (in contrast to the
long-term care structures serving school-aged chil-
dren). The existence of this structure could have had
a facilitating effect on the process of early diagnosis.
PP detection strategies based on key workers such
as childhood professionals and pediatricians could
implicitly lead to a passive attitude from child psychi-
atrists, whose roles are limited to the diagnostic and
assessment phase. In other words, child psychiatrists
have little to do with the detection phase; they simply
wait for referrals by pediatricians and primary care
physicians. A passive attitude replaces active collab-
oration through informal exchanges, networking, and
reciprocal information, reinforces insularity between
professions, and creates barriers to efﬁcient care.
Maintenance Strategies
Although our pilot program might have perpet-
uated itself and become self-sufﬁcient, our analysis
suggests an evident failure of any self-maintenance
effects. Maintenance strategies are crucial and require
adequate resources. Cost offsets emerging from
secondary prevention through early detection and
treatment could supply resources for maintenance
strategies. Apart from such marketing techniques
such as promotion, reminders, and other communi-
cations, structural modiﬁcations in the child and
adolescent mental health system could focus on early
detection and diagnosis. Creating special appoint-
ments could reinforce links between child psychia-
trists, pediatricians, and childhood professionals.
Special research programs could translate fundamen-
tal research ﬁndings into clinical practice as suggested
by the NIMH Blueprint for Change (Hoagwood &
Olin, 2002). Systematic screening strategies may also
be considered and could be combined with the
dissemination of PPs, which are an indispensable
complement to systematic screening and diagnosis.
Despite the fact that Switzerland is wealthy and
has a high rate of child and adolescent psychiatrists,
children with ASDs are not necessarily well served.
Differences between research settings and day-to-day
practice lead to much inefﬁciency. The usual care
processes need to be changed in depth, but child
psychiatrists remain ineffective on their own. Sensi-
tization and mobilization of child psychiatrists does
not alone produce signiﬁcant results in early detec-
tion. Primary care workers, early childhood workers,
and pediatricians need to be closely involved. They
are the best targets for early intervention programs to
the extent that child psychiatrists are reliable down-
stream resources. Lack of outcome expectations has
been identiﬁed as a barrier to adherence to clinical
practice guidelines (Cabana et al., 1999) and is
relevant for understanding resistance to change and
pediatricians’ skepticism toward child psychiatry.
The many competing child psychiatric theories of
autism, combined with limited care options and
modest treatment results, certainly reinforce pediatric
doubt. Further research is needed on the eﬀectiveness
of evidence-based treatment, translated into day-to-
day practice, in order to increase child mental health
outcome expectations and the conﬁdence of our
partners.
Changing clinical behavior is a complex and
difﬁcult task. Many strategies have been proposed,
ranging from inducement to coercion. There is little
doubt that the pharmaceutical industry applies some
of the most effective inducement techniques aimed at
modifying clinical behavior. Given the high cost and
the relatively aggressive nature of such techniques,
they cannot easily be transferred into a sensitive ﬁeld
such as childhood mental health, but they may be
considered. Coercive techniques come more from
insurance companies and managed care groups that
address economic issues, which are often in conﬂict
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with improving individual clinical care (Jellinek &
Little, 1998).
CONCLUSION
Are PPs a useful solution for delayed diagnosis?
Identiﬁed practice disparities lead to remediation
attempts and PPs appear to be a potentially effective
symptomatic treatment. PP development in the com-
plex ﬁeld of ASDs (where evidence-based recommen-
dations suffer from a lack of reliable hard data) has
engendered cautiousness and modesty. This limita-
tion elicits open recommendation of PPs similar to
those developed by the AACAP. Including speciﬁcity
of the local context while keeping a broad and
general usefulness requires compromise and a ﬂexible
theoretical orientation. This will produce a greater
likelihood of application and use. On the other hand,
too general a consideration and too little theoretical
background could be a barrier to adherence by
lowering expectations of health outcomes. As part of
a broad sequential and interdisciplinary chain, early
intervention is only the ﬁrst link in the chain. It is
necessary but not sufﬁcient.
Although several methodological limitations are
seen in this program, its strengths derive from
outcome assessments in day-to-day practice with a
simple but informative indicator such as mean-age-
at-diagnosis. Although difﬁcult to conduct and in
some ways disappointing, this program has high-
lighted inadequacies and has conﬁrmed chronic
trends. Potential practice improvements, although
temporary in our program, critically underline the
need for broader implementation strategies and
maintenance of PPs through active interdisciplinary
collaboration and politically supported actions. A
persuasive approach such as we have developed in
this pilot program seems feasible and reasonably
effective. For greatest effectiveness, it should be
associated as much as possible with a systematic
ASD screening and maintenance strategy.
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APPENDIX A
The PPs were circulated along with all accom-
panying steps and the development methodology.
For greater clarity, we limited ourselves to the
presentation of the clinical portion of the document.
Early Detection and Diagnosis
Our detection strategy involved the following
sequential steps leading either to a child psychiatry
consultation or to the JCNC.
1. Sensitization of the ﬁeld, that is, familiarizing
various early childhood professionals (nursery school
personnel, day care workers, specialized social work-
ers, educators) with developmental disorders and
with non-speciﬁc signs of possible ASDs, such as
social withdrawal, abnormalities in social reciprocity,
sharing enjoyment, directing attention etc. We
decided against using a speciﬁc tool in order to
reduce the risk of drifting towards alarmist positions
and abusive diagnosis. This was also important in
that the childhood facilities had no direct supervision
from the initiators of the PPs. The initial choice for
circulating an easily useable tool was reviewed, and
direct intervention by professionals was favored
(conference debates on this theme, presentations on
the course of elaboration of the PPs). We emphasized
that the identiﬁcation by ﬁeld professionals of non-
speciﬁc signs should be merely a starting point for a
consultation by a pediatrician or family doctor. This
course of sensitization constituted the ﬁrst step.
2. Informing pediatricians and general practitio-
ners of a speciﬁc tool: the CHAT (Checklist for
Autism in Toddlers). Our choice of this tool was
motivated by its simplicity of use, precise item
deﬁnitions, high speciﬁcity, and overall validity. Its
sensitivity, however, was lower than expected,
according to recent follow-up data to the age of
seven. While it is not a diagnostic tool, it does identify
children at risk. A failed CHAT (as it reveals a risk
proﬁle for a child who presents non-speciﬁc signs)
should lead the pediatrician or primary care physi-
cian to refer the child either to a child psychiatry
consultation or to the JCNC. This kind of screening
constituted the second step.
Diagnostic Investigation
Various steps were formalized and were gener-
ally in accordance with the recommendations devel-
oped by the AACAP. All diagnostic and assessment
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instruments mentioned were used by the JCNC and
remain indicative.
Pediatric Examination
The ﬁrst step of the consultation involved taking
a medical and psychological history of the child and a
description of the main presentation problems. The
ADI-R (Autism Diagnostic Interview Revised) could
be used at that point or later.
Historical Data were Notably Concerned with:
(a) the pregnancy, the perinatal period and the
developmental history that takes into account
the pregnancy, the delivery and neonatal
period. Special attention was paid to the
development stages of communication, lan-
guage, motor milestones, as well as to the
environmental responses. The question to
the parents about their ﬁrst recognition of
troubles was very important: When did they
ﬁrst start to worry about the development of
their child and why?
(b) The medical history: a ruling out of epilepsy,
sensorial deﬁcits, or medical signs evoking a
speciﬁc disorder (X fragile for example). The
question of previous pharmacological treat-
ment was important.
(c) The family history was reviewed for the
presence of other autism spectrum disorders.
Special attention was paid to siblings, given
the increased risk of ASDs in ﬁrst-degree
relatives.
(d) The psycho-social and familial factors were
taken into consideration within the perspec-
tive of evaluating environmental resources
and the speciﬁc vulnerabilities of the family
group. The coordinating role of the consul-
tant was particularly useful in the perspective
of a global evaluation, not purely limited to
medical or psychological aspects.
(e) Recapitulation of previous actions: the previ-
ous evaluations and the child’s response to
any treatment program had to be reviewed.
Pediatric Examination
(a) Principle objectives: check for pathologies
that would likely respond to medical treat-
ment (epilepsy for example), and/or that had
important consequences on the family level
(genetic predisposition such as X fragile or
tuberous sclerosis of Bourneville).
(b) The medical examination: check for pathol-
ogies frequently associated with autism,
which could guide the examination and lab-
oratory investigations. Neurological assess-
ment focusing on symptoms that suggest
seizures and a careful review of neurological
status were indicated. Longitudinal mea-
surements of head circumference, examina-
tion for dysmorphic or unusual features,
neurocutaneous abnormalities checked with
a Wood’s lamp examination, tone, gait, and
a cranial nerves examination were also indi-
cated.
(c) The audiological and visual examinations were
priorities. If an audiologic examination was
conducted, other auditory tests would be
required if there was any doubt as to audi-
tion. In the same manner, a vision examina-
tion would be carefully done.
Child Psychiatric Observation
Should take into account the environmental
aspects that would be likely to have an impact on
the child’s behavior, and that would not necessarily
be the same in the consultation, at the day nursery, or
at home. The clinician should be attentive to the
factors that have a positive or negative inﬂuence on
the participation of the child. His way of relating to
others and his manner of communication should be
carefully taken into account. Observations of the
child interacting with his parents should furnish
indications not only of the child, but also of the
parental response to the stress connected to the
child’s symptoms. Several sessions are generally
necessary for observation.
Special attention should be paid to developmen-
tal issues. Characteristic symptoms in the areas of
social interaction, language and communication, and
restricted or unusual interests and behaviors, should
be evaluated, as should associated behavioral difﬁ-
culties, such as self-injury and aggression.
We proposed the use of diagnostic assessment
scales, which we normally used.
For Children over 18 Months Old
A videotaped consultation, with a period of
relatively free examination of the child, and another
period for the use of a standardized diagnostic tool
(with the Childhood Autism Rating Scale, CARS).
Community Introduction of Practice Parameters 259
For Children Less than 18 months Old
A period of free examination, associated with the
use of a diagnostic observation tool, such as the
ERCA-N (Abbreviated evaluation of the autistic
behavior of the newborn) or the PL-ADOS (Pre-
Linguistic Autism Diagnostic Observation Schedule).
Psychological Assessment
Included the use of various tools
(a) Developmental and intelligence testing: the
choice of the test could vary according to
the characteristics of the child (age, devel-
opment level, language...). Brunet-Le´zine,
Borel-Maisonny, Termann-Merrill...
(b) Adaptive and behavioral assessment: more
speciﬁc tests (PEP-R: Psycho Educational
Proﬁle Revised; ECSP: scale of early social
communication by Guidetti and Tourette).
(c) Speech-language assessment: evaluating
vocabulary, language skills, oral-motor skills
and pragmatic skills.
The choice of tests was motivated by their
interest in the evaluation of different abilities, the
possibility of isolating relatively homogenous sub-
groups, and their large-scale use that allowed com-
parative studies. They are also adapted to the proﬁle
of the child. There is no arbitrary systematization
that requires each child to go through the same
battery of tests.
Other Assessments and Laboratory Investigations
These were done according to the signs presented
by the child. If none of these exams were carried out
systematically, we could nonetheless distinguish a




 Electroencephalography (checking signs of
epilepsy) that includes a marked course of
prolonged sleep patterns (systematically as-
sessed)
 genetic data (checking X fragile in particular)
for genetic counseling
 cerebral imaging (MRI)
 electrophysiological data (cortical or brain
stem evoked potential)
 occupational and physical therapy assessment
 routine laboratory studies with lead level
Other Foreseeable Examinations, such as:
 biochemical assessment checking metabolic
abnormalities
 study of the metabolism of the neurotrans-
mitters
Diagnostic Recapitulation
An important stage where the different elements
of the assessment are synthesized, where hypotheses
are formulated as well as a diagnosis allowing for
proposals of a treatment plan. An important role is
devoted to the clinician who is supposed to assume an
overall coordination of assessments and liaison with
different providers of intervention.
Treatment Plan
An appropriate treatment plan was proposed at
the end of the diagnostic step according to the
elements of this assessment. The treatment chosen
depended to a large extent on the wishes of the
parents, and the effective orientation depended on the
available options offered in each therapeutic area.
The treatment plan addressed goals for educational
intervention, target symptoms, and co-morbid con-
ditions, and monitored various functional areas.
Schematically, the types of treatment available
locally were the following, and were not necessarily
exclusive:
 Institutional treatment plan in a child psychi-
atric setting (internal therapeutic day hospital,
half-time therapeutic treatment center, partial
hospitalization)
 Institutional treatment in a pedagogic-educa-
tive or specialized re-educative setting
 School integration in an ordinary setting with
a specialized pedagogic aid
 Parent-infant therapeutic consultations
 Individual psychotherapeutic treatment
 Treatment focused on physical issues (physi-
cal therapy, sensorial integration)
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 Speech-language therapy
 Drug treatment
No treatment has been proven obviously supe-
rior in terms of therapeutic results. Nor are there
formal elements that would permit us to exclude one
or another form of treatment, arguing that they are
ineffective or even harmful. Nor is there a clear
consensus in favor of a speciﬁc method, but there is
evidence to support a multidisciplinary therapeutic
approach.
We have not found elements in the medical
literature that would allow us to determine a speciﬁc
therapeutic orientation relative to a pathological
proﬁle found in a framework of data. It is therefore
not possible now to propose practical recommenda-
tions for a global therapeutic orientation. This does
not reduce the importance of the initial assessment,
which allows us to specify the diagnosis and spot
dysfunction in certain areas. This orients the course
of therapy within an established treatment frame-
work. Further research is necessary in order to
evaluate the various therapeutic possibilities and
their respective indications.
The type of treatment usually recommended is
multidimensional, taking into account the different
aspects of the pathology (educative, social, and emo-
tional). Whatever the etiopathogenic model of these
problems might be, it seems important to us to keep a
broad perspective that is not limited to an exclusive
framework of understanding the problem (for exam-
ple, autism understood as being a deﬁcit or handicap
that would justify only an educative or rehabilitation
type of treatment). A broad perspective should inte-
grate other points of view (such as the notion of
autistic defenses, or even the factors that maintain the
pathology at the core of the family). The absence of
scientiﬁc validation for the etiopathogenic model on
which the treatment is based requires caution and an
open mind in selecting treatments, and a certain
rigor in their evaluation. Further clinical research
should be focused on the evaluation of different types
of treatment based on clinical outcomes.
APPENDIX B
Vaud demographics and child and adolescent
psychiatry global activity.
The Canton de Vaud has 628,000 inhabitants and
7500births a year.Aquarter of this population is under
19 years of age. Each year, a total of 5700 childrenwere
followed. Overall, there were 55,000 consultations and
3,900 new cases per year in the public sector.
The canton of Vaud includes 103 child and
adolescent psychiatrists (about 2/3 of whom work in
public clinics while the other 1/3 are in private
practice), 97 pediatricians and 539 general practitio-
ners.
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